Read the full stored bill text
HLS 26RS-987 REENGROSSED
2026 Regular Session
HOUSE BILL NO. 761
BY REPRESENTATIVES HILFERTY, ADAMS, BAYHAM, BILLINGS, WILFORD
CARTER, CHASSION, FISHER, GREEN, LACOMBE, LAFLEUR, TERRY
LANDRY, LARVADAIN, MARCELLE, MARTINEZ, PHELPS, SPELL,
TAYLOR, WALTERS, AND ZERINGUE
HEALTH/CANCER: Provides with respect to the advisory board created to recommend
new treatments for rare cancers
1 AN ACT
2 To amend and reenact R.S. 22:1076.1, relative to the advisory board for rare cancer
3 treatments; to provide for revisions to board composition; to provide for meetings
4 and reporting; to provide for effectiveness; and to provide for related matters.
5 Be it enacted by the Legislature of Louisiana:
6 Section 1. R.S. 22:1076.1 is hereby amended and reenacted to read as follows:
7 §1076.1. Advisory board; composition; recommendations for treatment of rare
8 cancers; meetings; rulemaking
9 A. There is hereby created within the department an advisory board that shall
10 review and provide medical recommendations to approve new treatments for rare
11 cancers. The advisory board shall be composed of the following seventeen
12 members:
13 (1) The commissioner or his designee.
14 (2) The secretary or designee of the Louisiana Department of Health.
15 (3) The Medicaid Director or designee of the Louisiana Department of
16 Health.
17 (4) The surgeon general or his designee.
Page 1 of 3
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.
HLS 26RS-987 REENGROSSED
HB NO. 761
1 (5) The executive director or designee of Taking Aim at Cancer in Louisiana
2 The Cancer Association of Louisiana.
3 (6) The chief executive officer of the Louisiana Association of Health Plans.
4 (7) The chief medical officer or designee of a managed care organization.
5 (8) The director or designee of the Louisiana Tumor Registry.
6 (9) The director or designee of the Pennington Biomedical Research Center.
7 (10) A designee of the Louisiana Cancer Research Center.
8 (11) A designee of the LSU Health Sciences Center at New Orleans,
9 specializing in oncology.
10 (12) A designee of the Tulane Medical School, specializing in oncology.
11 (13) A designee of the Xavier Ochsner College of Medicine.
12 (14) Two Four oncologists specializing in the treatments of rare cancers.
13 B.(1) The chairperson of the advisory board shall be the executive director
14 or designee of the Louisiana Cancer Research Center.
15 (2) The advisory board shall hold quarterly public meetings unless otherwise
16 provided by vote of the advisory board or by order of the chairperson. Within thirty
17 forty-five days of each meeting, the advisory board shall compile a report of its
18 findings and submit a formal written report to the legislature House Committee on
19 Insurance and the Senate Committee on Insurance.
20 C. The commissioner may promulgate and adopt administrative rules and
21 regulations in accordance with the Administrative Procedure Act as are necessary to
22 implement the provisions of this Section.
23 Section 2. This Act shall become effective upon signature by the governor or, if not
24 signed by the governor, upon expiration of the time for bills to become law without signature
25 by the governor, as provided by Article III, Section 18 of the Constitution of Louisiana. If
26 vetoed by the governor and subsequently approved by the legislature, this Act shall become
27 effective on the day following such approval.
Page 2 of 3
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.
HLS 26RS-987 REENGROSSED
HB NO. 761
DIGEST
The digest printed below was prepared by House Legislative Services. It constitutes no part
of the legislative instrument. The keyword, one-liner, abstract, and digest do not constitute
part of the law or proof or indicia of legislative intent. [R.S. 1:13(B) and 24:177(E)]
HB 761 Reengrossed 2026 Regular Session Hilferty
Abstract: Revises the composition of the advisory board for rare cancer treatments and
provides for meetings and reporting requirements.
Present law provides that the chairperson of the advisory board is the executive director or
designee of the La. Cancer Research Center.
Proposed law changes the executive director or a designee of Taking Aim at Cancer in La.
to the executive director of the Cancer Association of Louisiana to serve on the board.
Proposed law revises the board’s composition by increasing the number of oncologists who
sit on the board.
Present law creates an advisory board within the Dept. of Insurance to review and provide
medical recommendations for new treatments for rare cancers.
Present law requires the advisory board to hold quarterly public meetings unless otherwise
provided.
Proposed law changes the deadline for submitting written reports to the legislature from 30
to 45 days after each meeting and also requires that the reports be submitted to the House
and Senate committees on insurance, instead of the legislature.
Present law authorizes the commissioner to promulgate rules necessary to implement the
provisions of present law.
Proposed law retains present law.
Effective upon signature of governor or lapse of time for gubernatorial action.
(Amends R.S. 22:1076.1)
Summary of Amendments Adopted by House
The House Floor Amendments to the engrossed bill:
1. Changes one of the designated entities of the advisory board from Taking Aim
at Cancer in La. to the Cancer Association of La.
2. Establish an effective date upon the signature of the governor.
3. Make technical changes.
Page 3 of 3
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.